Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.335 AUD 4.04% Market Closed
Market Cap: 487.6m AUD
Have any thoughts about
Immutep Ltd?
Write Note

P/OCF
Price to OCF

-13.7
Current
-11.4
Median
21.6
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-13.7
=
Market Cap
486.7m AUD
/
Operating Cash Flow
-35.4m AUD
All Countries
Close
Market Cap P/OCF
AU
Immutep Ltd
ASX:IMM
486.7m AUD -13.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -237 646.1
US
Abbvie Inc
NYSE:ABBV
340.8B USD 20.6
US
Amgen Inc
NASDAQ:AMGN
156.4B USD 21.5
US
Gilead Sciences Inc
NASDAQ:GILD
129.7B USD 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.9B USD -239.4
US
Epizyme Inc
F:EPE
94.1B EUR -473.4
AU
CSL Ltd
ASX:CSL
124.5B AUD 28.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.8B USD 16.7
US
Seagen Inc
F:SGT
39.3B EUR -76.4
NL
argenx SE
XBRU:ARGX
36.3B EUR -146.9
 
AU
Immutep Ltd
ASX:IMM
Average P/OCF: 20.1
Negative Multiple: -13.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -237 646.1
US
Abbvie Inc
NYSE:ABBV
20.6
US
Amgen Inc
NASDAQ:AMGN
21.5
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -239.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -473.4
AU
CSL Ltd
ASX:CSL
28.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -146.9

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A